PTSM: Pharmaceutical Technology Sourcing and Management-01-04-2017

Alternatives to expensive palladium catalysts are gaining acceptance for commercial API synthesis.

With a healthy supply of biosimilars heading to the approval pipeline, will license holders turn to contract manufacturers for development and production?

Pharma Tech introduced a new high-speed bottling line to its facility in Union, MO.

AGC adds second biopharma contract manufacturer with acquisition of CMC Biologics.

Novasep’s three facilities located in France and Germany are free of Form 483.

The company has manufactured double-digit number of batches on the new filling line, for use in early-stage clinical trials.

The companies entered into a manufacturing agreement for voclosporin active pharmaceutical ingredient.

The two companies have entered into an agreement to provide Suzeken with access to AmerisourceBergen’s Cubixx inventory solution.

The $2-billion facility will be located in Clayton, North Carolina.

Lonza adds CDMO, capsule, and consumer healthcare and nutrition capabilities with $5.5-billion acquisition of Capsugel.

DuPont received a grant from the Bill & Melinda Gates Foundation to produce pharmaceutical proteins.

Saneca Pharma has received a EUR1.5 million grant from the Slovak Ministry of Education, Science, Research, and Sport, which will be used to drive forward new R&D initiatives for API manufacturing.